3004.60.00.00 - Other, containing antimalarial active principles described in subheading note 2 to this chapter 🖩

This HTS category, 3004.60.00.00, specifically addresses medicaments containing antimalarial active principles. These products are intended for the therapeutic or prophylactic treatment of malaria, a disease caused by parasites transmitted through mosquito bites. The key defining characteristic for this classification is the presence of active ingredients identified in subheading note 2 to Chapter 30 of the Harmonized Tariff Schedule. These notes provide specific guidance on which substances are considered antimalarial active principles for classification purposes.

This classification is distinct from other medicaments classified under heading 3004 that contain different active principles. For instance, it does not include antibiotics (3004.20.00), penicillins or their derivatives (3004.10), hormones, alkaloids, or vitamins. The focus here is solely on products designed to combat malaria.

As this is a leaf node in the HTS structure, there are no further subcategories. Therefore, classification within 3004.60.00.00 depends entirely on the identification of an antimalarial active principle as defined by the relevant subheading note. This means that the precise chemical composition and stated therapeutic use for malaria are paramount for correct classification. Examples of products that would fall here include tablets, capsules, or injectables formulated with known antimalarial drugs.